Barinthus Biotherapeutics plc. (BRNS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$70.56M | -3.8% |
| 2024 | -$67.97M | +19.0% |
| 2023 | -$83.91M | -1976.6% |
| 2022 | -$4.04M | +91.1% |
| 2021 | -$45.22M | -125.6% |
| 2020 | -$20.05M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$70.56M | -3.8% |
| 2024 | -$67.97M | +19.0% |
| 2023 | -$83.91M | -1976.6% |
| 2022 | -$4.04M | +91.1% |
| 2021 | -$45.22M | -125.6% |
| 2020 | -$20.05M | — |